-+ 0.00%
-+ 0.00%
-+ 0.00%

Halozyme Therapeutics Q3 revenue jumps 39% on ENHANZE royalty growth, lifts 2026 outlook

路透·11/05/2026 21:48:29

請登錄查看新聞詳情